JD Health may launch its IPO on Nov. 25 and list its shares on Dec. 8, targeting on raising USD $4 billion (RMB 26.3 billion yuan) in capital to reach the valuation at USD $29 billion (RMB 191 billion yuan). JD Health has filed a post-hearing information kit with the Stock Exchange of Hong Kong (HKSE) for the proposed spin-off for publication on the HKSE website.
According to JingDong’s IPO prospectus, JD Health’s revenue in the first half of 2020 will be RMB 8.8 billion yuan (USD $1.34 billion), up 76% year-on-year, with the average daily consultation volume in the first half of 2020 will increase six times compared to the same period in 2019. Currently, the annual active users of JD Health have reached 72.5 million, and there are more than 65,000 doctors stationed on the platform. At the same time, JD Health is working to build an omnichannel service system. The company’s retail and wholesale business already cover pharmaceuticals, medical devices, health care products and other generic health products, to provide users with an integrated online and offline service path. (Source: qq.com)